Article info
PostScript
Letter
Benefit versus toxicity risk of digoxin in patients with COVID-19
- Correspondence to Mrs Burcu Kelleci Cakir, Department of Clinical Pharmacy, Hacettepe University Faculty of Pharmacy, 06100 Ankara, Turkey; burcukelleci{at}hacettepe.edu.tr
Citation
Benefit versus toxicity risk of digoxin in patients with COVID-19
Publication history
- First published June 2, 2021.
Online issue publication
October 25, 2022
Article Versions
- Previous version (2 June 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© European Association of Hospital Pharmacists 2022. No commercial re-use. See rights and permissions. Published by BMJ.